The most important financial indicators for the company Novartis Pharma Services Romania Srl - Unique Identification Number 27813234:
sales in 2023 was
238.324.384
euro, registering a net profit of
6.257.952
euro and having an average number of
192
employees.
Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 18.2%, from 202.182.125 euro in the year 2022, to 238.324.384 euro in 2023.
The Net Profit increased by 128.410 euro, from 6.148.187 euro in 2022, to 6.257.952 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Novartis Pharma Services Romania Srl - CUI 27813234
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
1.944.523
1.677.090
1.386.427
586.090
-
562.061
409.288
1.041.825
846.889
948.971
Current Assets
75.686.169
65.114.334
84.298.745
97.112.177
-
125.990.107
133.832.735
118.348.399
151.506.712
210.371.401
Inventories
36.936.279
17.244.559
31.645.171
32.893.734
-
41.121.179
41.716.628
34.226.942
56.123.851
75.883.100
Receivables
38.569.969
45.905.021
52.637.036
64.074.578
-
81.468.901
91.169.592
84.037.212
95.314.155
111.277.470
Cash
179.922
1.964.754
16.538
143.864
-
3.400.026
946.515
84.244
68.706
23.210.830
Shareholders Funds
3.362.185
7.378.309
10.878.031
12.331.790
-
22.364.997
23.247.437
29.745.973
35.986.447
42.135.272
Social Capital
669.329
674.916
668.032
656.728
-
632.191
620.206
606.453
608.334
606.489
Debts
74.328.836
59.609.683
74.842.350
81.391.600
-
102.492.544
111.136.268
89.719.027
116.390.287
168.988.004
Income in Advance
0
0
0
0
-
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
210.371.401 euro in 2023 which includes Inventories of
75.883.100 euro, Receivables of
111.277.470 euro and cash availability of
23.210.830 euro.
The company's Equity was valued at
42.135.272 euro, while total Liabilities amounted to
168.988.004 euro.
Equity increased by 6.257.952 euro, from 35.986.447 euro in 2022, to 42.135.272 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Novartis Pharma Services Romania Srl